医学
全膝关节置换术
围手术期
随机对照试验
预热
骨科手术
术后恶心呕吐
恶心
麻醉
前瞻性队列研究
临床路径
外科
临床试验
物理疗法
内科学
护理部
作者
Chenxi Liao,Xingning Lai,Jie Zhong,Wencong Zeng,Jiannan Zhang,Wanxin Deng,Jiayun Shu,Haobo Zhong,Liangyu Cai,Ren Liao
标识
DOI:10.1186/s40001-025-02647-8
摘要
BACKGROUND: The proportion of elderly patients undergoing Total knee arthroplasty (TKA) is growing. Optimizing and accelerating postoperative recovery for TKA patients is critical in clinical practice. Enhanced Recovery After Surgery (ERAS) is a protocol involving a series of evidence-based perioperative optimization strategies to minimize surgical stress and expedite recovery, and a multidisciplinary ERAS pathway was established jointly by anesthesiologists and orthopedic surgeons in this study. The authors hypothesized that application of the ERAS pathway can reduce the length of hospital stay (LOS) for patients undergoing primary TKA. MATERIALS AND METHODS: This multicenter, prospective, randomized controlled trial was conducted from February 1, 2021 to January 31, 2023, and included patients undergoing elective primary TKA. 320 patients were randomly assigned to either the ERAS group (practice according to the ERAS pathway) or the control group (without ERAS pathway implementation) in a 1:1 ratio. The primary outcome was the total LOS in hospital. RESULTS: LOS in the ERAS group was 5.92 ± 1.16 days, significantly shorter than the 8.17 ± 1.76 days in the control group (p < 0.001). Postoperative LOS and time to independent ambulation were significantly shorter in the ERAS group compared to the control group (p < 0.001). On postoperative day 1, significantly less participants reported pain both in rest and during mobilization in the ERAS group than the control group (p < 0.001). The incidences of thirst and postoperative nausea and vomiting (PONV) was significantly reduced in the ERAS group compared to the control group (16.8% vs. 88.6%, and 2.6% vs. 24.7%, respectively, p < 0.001). No perioperative deaths or reoperations within 30 days occurred in either group. CONCLUSION: The application of an ERAS pathway for primary TKA significantly reduces LOS, alleviates postoperative pain, and lowers the incidence of adverse events compared to perioperative management without ERAS pathway implementation. TRIAL REGISTRATION: The National Institutes of Health Clinical Trials Registry, NCT03517098. Registered on April 24, 2018.
科研通智能强力驱动
Strongly Powered by AbleSci AI